@seanenright_ Profile picture

Sean Enright

@seanenright_

Inari Medical

Similar User
Rdub mkonkkel photo

@Rdubskeet34

Billy Hadley photo

@Bhad_88

Dan Scherer photo

@Gyeah101

Keith Inman photo

@Keith_Inman

PG photo

@RealPG5

Pat Guido photo

@dacubbies2430

Around The Herd photo

@AroundTheHerd

Jeff Delvalle photo

@Jeffy_BoomBoom

JDF photo

@jdidiana

Sean Enright Reposted

Big East Men's Assists per game leaders entering today: Conor Enright (@DePaulHoops): 7.6 Steven Ashworth (@BluejayMBB): 7.0 Kameron Jones (@MarquetteMBB): 6.0 Kadary Richmond (@StJohnsBBall): 5.8 Deivon Smith (@StJohnsBBall): 5.5 Jhamir Brickus (@NovaMBB): 4.8


Sean Enright Reposted

Conor Enright making things happen. 4:50 2H | DePaul 61, EIU 55


Sean Enright Reposted

#PEERLESS results show a clear win for #FlowTriever on the 5-component win ratio primary endpoint. Patients experienced: - 3X fewer deteriorations and/or therapy escalations - Better, faster recovery of symptoms and hemodynamics - Less ICU utilization, hospital LOS, and…


Sean Enright Reposted

put it in the spin cycle 🔁 15:37 2H | DePaul 53, Duquesne 37


Sean Enright Reposted

Rush University Department of Vascular and Interventional Radiology is officially approved as of this morning. Hope more IR/VIR departments to come to advance our field! @kmadass @JTassMD @RSP516 @riadsalemIR


Sean Enright Reposted

#PEERLESS results show a clear win for #FlowTriever on the 5-component win ratio primary endpoint. Patients experienced: - 3X fewer deteriorations and/or therapy escalations - Better, faster recovery of symptoms & hemodynamics - Less ICU utilization, hospital LOS, and…

Tweet Image 1

Sean Enright Reposted

Earlier today, Dr. Wissam Jaber (Co-PI) presented #PEERLESS results LIVE from #TCT2024. PEERLESS met its primary composite endpoint (win ratio 5.01, p<0.001), driven by patients experiencing significantly fewer clinical deteriorations or therapy escalations, fewer ICU…

Tweet Image 1
Tweet Image 2
Tweet Image 3

Sean Enright Reposted

What a great weekend for the Inaugural #PVTL PVD course. Thanks to all that made it happen⬇️ 🙏🏽🥃 linkedin.com/posts/kumar-ma…


Sean Enright Reposted

Superior clinical evidence and the lowest episode care costs make #ClotTriever the intelligent choice for #DVT thrombectomy. Check out the recent #JVS-VI publication that showed total care costs were $3,400 less with ClotTriever compared to continuous aspiration thrombectomy for…

Tweet Image 1

Sean Enright Reposted

Use of the Protrieve Sheath during venous mechanical thrombectomy resulted in favorable technical and clinical outcomes without device related adverse events or thromboembolic events. @cvirendo @EVToday @InariMedical @CVIR_Journal @_backtable @UWRadiology @JVIRmedia

Tweet Image 1
Tweet Image 2
Tweet Image 3
Tweet Image 4

Sean Enright Reposted

The RevCore thrombectomy catheter is the first mechanical thrombectomy device engineered specifically for venous stent thrombosis, offering safe and effective clot removal while restoring stent patency in a single session. With its ability to handle various stent types and…


Sean Enright Reposted

Real-world analysis from Premier #PINCAI comparing PE patients treated w/ #FlowTriever vs. Penumbra Indigo: - 4,000+ PE patients - Adjusted for population differences - FlowTriever showed lower in-hospital mortality & less adjunctive lytic use More: bit.ly/4bUyMml


Sean Enright Reposted

I am very proud of @InariMedical for proactively and voluntarily updating the IFU for ClotTriever XL (CTXL) and reaching out to the FDA to ensure alignment. I wanted to clarify to the medical community what the changes are (1/5)


Sean Enright Reposted

US HCPs: LARGEST independent retrospective analysis of #FlowTriever at a major university medical center confirms safety and effectiveness for the treatment of high- and intermediate-risk #PE patients. Read more: bit.ly/4dYqz1V More on FT: bit.ly/4dHrsfk


Sean Enright Reposted

When it comes to treating #DVT, long-term patient outcomes matter. #CLOUT 2-year interim outcomes show sustained improvement in PTS symptoms at 2 years. More on CLOUT: bit.ly/3UWOO8O #safety #effectiveness #evidence


Sean Enright Reposted

"Of all the advancements in PE #thrombectomy, the FlowSaver is the biggest." Drs. Ripal Gandhi and @AndrewNiekampMD discuss how the #FlowSaver Blood Return System allows interventionalists to focus on clinically meaningful endpoints and treat patients more effectively. Learn…


Sean Enright Reposted

Shout out to our Loyola PERT team @JacobAClarke @QMalleryMD @DSutherlandMD helping make our video highlighting the impactful lessons we learned in past PERT consortium meetings. If you have an interest in PE, this is the one meeting you need to be at. @LUcardsfellows


Sean Enright Reposted

The @LoyolaHealth team is gearing up for #PERT2024, and they’re sharing why you should be there too! From groundbreaking research to life-saving innovations, discover why this Is a must-attend event: pertconsortium.org/pert-annual-sy…


Sean Enright Reposted

🆕Insights from the PINC AI Healthcare Database on #MechanicalThrombectomy for #DeepVeinThrombosis 💡Results suggest #MT interventions may be unequal in terms of outcomes & resources. Derek Mittleider, Matt Finn, & @sahilparikhmd discuss. Watch now: 📽️youtu.be/SdyJ28U73OE


Sean Enright Reposted

A Real-World Analysis of Clinical and Economic Outcomes with #ClotTriever: The PINC AI Healthcare Database #DVT Analysis Read more: bit.ly/3LN9r3a #thrombectomy #VTE


Loading...

Something went wrong.


Something went wrong.